Diabetes drug Dialon withdrawn from UAE market
Health Ministry issues circular to withdraw Julphar product
Abu Dhabi: The Ministry of Health and Prevention issued a circular to medical zones, hospitals and pharmacies to withdraw Dialon 500mg, which is used to treat diabetes, due to its dissolution failure.
Dialon, manufactured by the Gulf Pharmaceutical Industries, Julphar, contains effective substance called Metformin. The drug failed to provide the required solubility as shown by studies.
The decision to withdraw the drug from the UAE market follows an inspection visit carried out by the ministry’s inspectors to Julphar factory.
The ministry also received another a report from the Saudi Food and Drug Authority indicating the solubility failure of this pharmaceutical product for the same reason.